8-aminoquinoline has been researched along with paromomycin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sundar, S | 1 |
| Boelaert, M; Bryceson, AD; Croft, SL; Desjeux, P; Guerin, PJ; Olliaro, P; Sundar, S; Wasunna, MK | 1 |
| Desjeux, P | 1 |
| Berman, J | 1 |
| Pandey, HP; Singh, RK; Sundar, S | 1 |
| Kulshrestha, A; Kumar, D; Negi, NS; Salotra, P; Singh, R | 1 |
| Kumar, M; Singh, N; Singh, RK | 1 |
4 review(s) available for 8-aminoquinoline and paromomycin
| Article | Year |
|---|---|
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Asia, Western; Brazil; Developing Countries; Dogs; Female; Humans; Leishmaniasis, Visceral; Male; Paromomycin; Phosphorylcholine; Sudan | 2002 |
Clinical status of agents being developed for leishmaniasis.
Topics: Aminoquinolines; Antiprotozoal Agents; Fluconazole; Humans; Imiquimod; Ketoconazole; Leishmaniasis; Paromomycin; Phosphorylcholine | 2005 |
Visceral leishmaniasis (kala-azar): challenges ahead.
Topics: Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; India; Leishmania; Leishmaniasis, Visceral; Lipids; Paromomycin; Public Health; Sensitivity and Specificity | 2006 |
Leishmaniasis: current status of available drugs and new potential drug targets.
Topics: Aminoquinolines; Amphotericin B; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Caspase Inhibitors; Cyclin-Dependent Kinases; Drug Discovery; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Leishmaniasis; Macrophages; Microbodies; Mitogen-Activated Protein Kinase Kinases; Paromomycin; Pentamidine; Phosphorylcholine; Polyamines; Protease Inhibitors; Sterols; Sulfhydryl Compounds; Topoisomerase Inhibitors | 2012 |
3 other study(ies) available for 8-aminoquinoline and paromomycin
| Article | Year |
|---|---|
Drug resistance in Indian visceral leishmaniasis.
Topics: Aminoquinolines; Amphotericin B; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Resistance; Geography; History, 20th Century; History, 21st Century; Humans; India; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine; Treatment Outcome | 2001 |
[Therapeutic options for visceral leishmaniasis].
Topics: Aminoquinolines; Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Paromomycin | 2005 |
Antimony-resistant clinical isolates of Leishmania donovani are susceptible to paromomycin and sitamaquine.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Cells, Cultured; Drug Resistance; Humans; Leishmania donovani; Macrophages; Mice; Nitric Oxide; Paromomycin | 2011 |